Hyposplenism: A comprehensive review. Part I: Basic concepts and causes

Hematology

Volumn 12, Issue 1, 2007, Pages 1-13

  William, Basem M ^a   Corazza, Gino R ^b  

^a EASTERN MAINE MEDICAL CENTER   (United States)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Asplenia; Celiac disease; Hyposplenism; Sickle cell; Sylenic hypofunction

Indexed keywords

ALCOHOL; AUTOANTIBODY; CORTICOSTEROID; HEMOGLOBIN F; HEMOGLOBIN S; HYDROXYUREA; IMMUNOGLOBULIN M ANTIBODY; METHYLDOPA; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; STEROID; TECHNETIUM SULFUR COLLOID TC 99M; TUFTSIN;

ALCOHOL ABSTINENCE; ALCOHOL LIVER DISEASE; ALLOGENIC BONE MARROW TRANSPLANTATION; AMYLOIDOSIS; ASPLENIA; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; BACTERIAL INFECTION; BLOOD SMEAR; BLOOD TRANSFUSION; CANCER RADIOTHERAPY; CELIAC DISEASE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; ENTERITIS; ERYTHROCYTE COUNT; GLUTEN FREE DIET; HEMATOLOGIC DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOSPLENISM; IMMUNOGLOBULIN PRODUCTION; IMMUNOPATHOGENESIS; INCIDENCE; INTRAVENOUS FEEDING; ISOTOPE LABELING; LYMPHOCYTOSIS; MEMORY CELL; MESENTERY LYMPH NODE; MONOCYTOSIS; MORTALITY; NEOPLASM; PRIORITY JOURNAL; PROGNOSIS; RETICULOENDOTHELIAL SYSTEM; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SEPSIS; SICKLE CELL ANEMIA; SOLID TUMOR; SPLEEN BLOOD FLOW; SPLEEN DISEASE; SPLEEN FUNCTION; SPLEEN SIZE; SPLEEN WEIGHT; SPLENECTOMY; SPLENOMEGALY; STREPTOCOCCUS INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS; ULCERATIVE COLITIS; VASCULAR DISEASE;

ADULT; AGED; ANEMIA, SICKLE CELL; AUTOIMMUNE DISEASES; B-LYMPHOCYTE SUBSETS; BACTERIAL INFECTIONS; CELIAC DISEASE; CHILD; DISEASE SUSCEPTIBILITY; GASTROINTESTINAL DISEASES; HEMATOLOGIC DISEASES; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC MEMORY; INFANT, NEWBORN; LIVER DISEASES; NEOPLASMS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEPSIS; SPLEEN; SPLENECTOMY; SPLENIC DISEASES; T-LYMPHOCYTE SUBSETS; VACCINATION;

EID: 33947177107     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330600938422     Document Type: Review

References (193)

1. Doll, DC, List, AF and Yarbro, JW (1987) Functional hyposplenism. South Med J, 80, pp. 999-1006.
2. Erslev, AJ (2001) Hypersplenism and hyposplenism. Williams hematology, pp. 683-687. McGraw-Hill, New York, NY
3. Eppinger, H. (1913) Zur pathologie der milzfunktion. Klin Wochenschr, 50, pp. 1509-1512.
4. Dameshek, W. (1955) Hypersplenism. Bull NY Acad Sci, 31, p. 113.
5. Schilling, V. (1924) Uber die diagnose einer milzatrophie durch den befund von kernkugelin als teilersche teilerscheiung pluriglandularer insuffzienz. Klin Wochenschr, 43, pp. 1960-1962.
6. Dameshek, W. (1955) Hyposplenism (Letter). JAMA, 157, p. 163.
7. Chen, LT (1978) Microcirculation of the spleen: And open or closed circulation?. Science, 201, pp. 157-159.
8. Weiss, L. (1974) A scanning electron microscopic study of the spleen. Blood, 43, pp. 665-691.
9. Schulkind, ML Ellis, EF and Smith, RT (1967) Effect of antibody upon clearance of I-125-labelled pneumococci by the spleen and liver. Pediatr Res, 1, pp. 178-184.
10. Rowley, DA (1950) The formation of circulating antibody in the splenectomized human being following intravenous injection of heterologous erythrocytes. J Immunol, 65, p. 515.
11. Likhite, VV (1976) Immunological impairment and susceptibility to infection after splenectomy. JAMA, 236, pp. 1376-1377.
12. Eichner, ER (1979) Splenic function: Normal, too much and too little. Am J Med, 66, pp. 311-320.
13. Constantopoulos, A., Najjar, VA, Wish, JB, Necheles, TH and Stolbach, LL (1973) Defective phagocytosis due to tuftsin deficiency in splenectomized subjects. Am J Dis Child, 125, pp. 663-665.
14. Spirer, Z., Zakuth, V., Diamant, S., Mondorf, W., Stefanescu, T. and Stabinsky, Y. (1977) Decreased tuftsin concentrations in patients who have undergone splenectomy. Br Med J, 2, pp. 1574-1576.
15. Constantopoulos, A., Likhite, V.,Crosby, WH and Najjar, VA (1973) Phagocytic activity of the leukemic cell and its response to the phagocytosis-stimulating tetrapeptide, tuftsin. Cancer Res, 33, pp. 1230-1234.
16. Spirer, Z., Zakuth, V., Diamant, S., Mondorf, W., Stefanescu, T. and Stabinsky, Y. (1977) Decreased tuftsin concentrations in patients who have undergone splenectomy. Br Med J, 2, pp. 1574-1576.
17. Spirer, Z., Weisman, Y., Zakuth, V., Fridkin, M. and Bogair, N. (1980) Decreased serum tuftsin concentrations in sickle cell disease. Arch Dis Child, 55, pp. 566-567.
18. Corazza, GR, Zoli, G., Ginaldi, L., Cancellieri, C., Profeta, V. and Gasbarrini, G. (1991) Tuftsin deficiency in AIDS. Lancet, 337, pp. 12-13.
19. Corazza, GR, Zoli, G., Sabatino, A Di, Ciccocioppo, R. and Gasbarrini, G. (1999) A reassessment of splenic hypofunction in celiac disease. Am J Gastroenterol, 94, pp. 391-397.
20. Trevisani, F., Castelli, E., Foschi, FG, Parazza, M., Loggi, E. and Bertelli, M. (2002) Impaired tuftsin activity in cirrhosis: Relationship with splenic function and clinical outcome. Gut, 50, pp. 707-712.
21. Kruetzmann, S., Rosado, MM, Weber, H., Germing, U., Tournilhac, O. and Peter, HH (2003) Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med, 197, pp. 939-945.
22. Forster, I. and Rajewsky, K. (1987) Expansion and functional activity of Ly-1+B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur J Immunol, 17, pp. 521-528.
23. Wardemann, H., Boehm, T., Dear, N. and Carsetti, R. (2002) B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J Exp Med, 195, pp. 771-780.
24. Klein, U., Rajewsky, K. and Kuppers, R. (1998) Human immunoglobulin (Ig)M+IgD+peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med, 188, pp. 1679-1689.
25. Liu, YJ, Malisan, F., de Bouteiller, O., Guret, C., Lebecque, S. and Banchereau, J. (1996) Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity, 4, pp. 241-250.
26. Klein, U., Rajewsky, K. and Kuppers, R. (1998) Human immunoglobulin (Ig)M+IgD+peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med, 188, pp. 1679-1689.
27. Kruetzmann, S., Rosado, MM, Weber, H., Germing, U., Tournilhac, O. and Peter, HH (2003) Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med, 197, pp. 939-945.
28. Eichner, ER (1979) Splenic function: Normal, too much and too little. Am J Med, 66, pp. 311-320.
29. McBride, JA, Dacie, JV and Shapley, R. (1968) The effect of splenectomy on the leucocyte count. Br J Haematol, 14, pp. 225-231.
30. Spencer, RP, Pearson, HA and Binder, HJ (1970) Identification of cases of "acquired" functional asplenia. J Nucl Med, 11, pp. 763-766.
31. Pearson, HA, Spencer, RP and Cornelius, EA (1969) Functional asplenia in sickle-cell anemia. N Engl J Med, 281, pp. 923-926.
32. Steinberg, MH, Gatling, RR and Tavassoli, M. (1983) Evidence of hyposplenism in the presence of splenomegaly. Scand J Haematol, 31, pp. 437-439.
33. Muller, AF and Toghill, PJ (1992) Splenic function in alcoholic liver disease. Gut, 33, pp. 1386-1389.
34. Stockman III, JA and Oski, FA (1978) Erythrocytes of the human neonate. Curr Top Hematol, 1, pp. 193-232.
35. Holroyde, CP, Oski, FA and Gardner, FH (1969) The "pocked" erythrocyte. Red-cell surface alterations in reticuloendothelial immaturity of the neonate. N Engl J Med, 281, pp. 516-520.
36. Rose, V., Izukawa, T. and Moes, CA (1975) Syndromes of asplenia and polysplenia. A review of cardiac and non-cardiac malformations in 60 cases withspecial reference to diagnosis and prognosis. Br Heart J, 37, pp. 840-852.
37. Ivemark, B. (1955) Implications of agenesis of the spleen on the pathogenesis of cono-truncus anomalies in childhood. Acta Paediatr, 44, pp. 1-110.
38. Rose, V., Izukawa, T. and Moes, CA (1975) Syndromes of asplenia and polysplenia. A review of cardiac and non-cardiac malformations in 60 cases with special reference to diagnosis and prognosis. Br Heart J, 37, pp. 840-852.
39. Britz-Cunningham, SH, Shah, MM, Zuppan, CW and Fletcher, WH (1995) Mutations of the Connexin43 gap-junction gene in patients with heart malformations and defects of laterality. N Engl J Med, 332, pp. 1323-1329.
40. Pearson, HA, Schiebler, GL and Spencer, RP (1971) Functional hyposplenia in cyanotic congenital heart disease. Pediatrics, 48, pp. 277-280.
41. Bjorses, P., Pelto-Huikko, M., Kaukonen, J., Aaltonen, J., Peltonen, L. and Ulmanen, I. (1999) Localization of the APECED protein in distinct nuclear structures. Hum Mol Genet, 8, pp. 259-266.
42. Bjorses, P., Aaltonen, J., Horelli-Kuitunen, N., Yaspo, ML and Peltonen, L. (1998) Gene defect behind APECED: A new clue to autoimmunity. Hum Mol Genet, 7, pp. 1547-1553.
43. Starzyk, J., Kumorowicz-Kopiec, M., Kowalczyk, M., Starzyk, B., Rybakowa, M. and Dziatkowiak, H. (2001) Natural history of asplenism in APECED-patient report. J Pediatr Endocrinol Metab, 14, pp. 443-449.
44. Stormorken, H. (2002) Stormorken's syndrome. Tidsskr Nor Laegeforen, 122, pp. 2853-2856.
45. Alvarez, O., Miller, JH and Coates, TD (1992) Thrombocytosis and hyposplenism in an infant with fetal hydantoin syndrome. Am J Pediatr Hematol Oncol, 14, pp. 62-65.
46. Freeman, SB, Muralidharan, K., Pettay, D., Blackston, RD and May, KM (1996) Asplenia syndrome in a child with a balanced reciprocal translocation of chromosomes 11 and 20 [46,XX,t(11;20)(q13.1;q13.13)]. Am J Med Genet, 61, pp. 340-344.
47. Robinson, RG, Adler, R., Swanson, VL, Williams, KO and Siegel, SE (1982) Congenital hypoplastic anemia (CHA) associated with congenital absence of the spleen. Am J Pediatr Hematol Oncol, 4, pp. 341-344.
48. Diggs, LW (1935) Siderofibrsosis of the spleen in sickle cell anemia. JAMA, 104, pp. 538-541.
49. Jenkins, ME, Scott, RB and Baird, RL (1960) Studies in sickle cell anemia. XVI Sudden death during sickle cell anemia crisis in young children. J Pediat, 56, pp. 30-38.
50. Pearson, HA, Spencer, RP and Cornelius, EA (1969) Functional asplenia in sickle-cell anemia. N Engl J Med, 281, pp. 923-926.
51. Pearson, HA, Spencer, RP and Cornelius, EA (1969) Functional asplenia in sickle-cell anemia. N Engl J Med, 281, pp. 923-926.
52. Pearson, HA, McIntosh, S., Ritchey, AK, Lobel, JS, Rooks, Y. and Johnston, D. (1979) Developmental aspects of splenic function in sickle cell diseases. Blood, 53, pp. 358-365.
53. Wali, YA, Lamki, Z Al, Hussein, SS, Bererhi, H., Kumar, D. and Wasifuddin, S. (2002) Splenic function in Omani children with sickle cell disease: Correlation with severity index, hemoglobin phenotype, iron status, and alpha-thalassemia trait. Pediatr Hematol Oncol, 19, pp. 491-500.
54. Mallouh, A., Burke, GM, Salamah, M. and Ahmad, MS (1984) Splenic function in Saudi children with sickle cell disease. Ann Trop Paediatr, 4, pp. 87-91.
55. Mallouh, A., Burke, GM, Salamah, M. and Ahmad, MS (1984) Splenic function in Saudi children with sickle cell disease. Ann Trop Paediatr, 4, pp. 87-91.
56. Mouzan, MI el, Awamy, BH al, Torki, MT al and Niazi, GA (1989) Variability of sickle cell disease in the eastern province of Saudi Arabia. J Pediatr, 114, pp. 973-976.
57. Awamy, B Al, Wilson, WA and Pearson, HA (1984) Splenic function in sickle cell disease in the eastern province of Saudi Arabia. J Pediatr, 104, pp. 714-717.
58. Adekile, AD, McKie, KM, Adeodu, OO, Sulzer, AJ, Liu, JS and McKie, VC (1993) Spleen in sickle cell anemia: Comparative studies of Nigerian and U.S. patients. Am J Hematol, 42, pp. 316-321.
59. Pearson, HA, Spencer, RP and Cornelius, EA (1969) Functional asplenia in sickle-cell anemia. N Engl J Med, 281, pp. 923-926.
60. Gill, FM, Sleeper, LA, Weiner, SJ, Brown, AK, Bellevue, R. and Grover, R. (1995) Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative study of sickle cell disease. Blood, 86, pp. 776-783.
61. Garnett, ES, Goddard, BA, Markby, D. and Webber, CE (1969) The spleen as an arteriovenous shunt. Lancet, 1, pp. 386-388.
62. Pearson, HA, Spencer, RP and Cornelius, EA (1969) Functional asplenia in sickle-cell anemia. N Engl J Med, 281, pp. 923-926.
63. Spirer, Z., Weisman, Y., Zakuth, V., Fridkin, M. and Bogair, N. (1980) Decreased serum tuftsin concentrations in sickle cell disease. Arch Dis Child, 55, pp. 566-567.
64. Raghupathy, R., Haider, MZ, Azizieh, F., Abdelsalam, R., D'Souza, TM and Adekile, AD (2000) Th1 and Th2 cytokine profiles in sickle cell disease. Acta Haematol, 103, pp. 197-202.
65. Pearson, HA, Cornelius, EA, Schwartz, AD, Zelson, JH, Wolfson, SL and Spencer, RP (1970) Transfusion-reversible functional asplenia in young children with sickle-cell anemia. N Engl J Med, 283, pp. 334-337.
66. Barrios, NJ, Livaudais, F., McNeil, J., Humbert, JR and Corrigan, J. (1993) Reversible splenic hypofunction in hypertransfused children with homozygous sickle cell disease. J Natl Med Assoc, 85, pp. 677-680.
67. Pearson, HA, Cornelius, EA, Schwartz, AD, Zelson, JH, Wolfson, SL and Spencer, RP (1970) Transfusion-reversible functional asplenia in young children with sickle-cell anemia. N Engl J Med, 283, pp. 334-337.
68. Campbell, PJ, Olatunji, PO, Ryan, KE and Davies, SC (1997) Splenic regrowth in sickle cell anaemia following hypertransfusion. Br J Haematol, 96, pp. 77-79.
69. Ferster, A., Bujan, W., Corazza, F., Devalck, C., Fondu, P. and Toppet, M. (1993) Bone marrow transplantation corrects the splenic reticuloendothelial dysfunction in sickle cell anemia. Blood, 81, pp. 1102-1105.
70. Santos, A., Pinheiro, V., Anjos, C., Brandalise, S., Fahel, F. and Lima, M. (2002) Scintigraphic follow-up of the effects of therapy with hydroxyurea on splenic function in patients with sickle cell disease. Eur J Nucl Med Mol Imaging, 29, pp. 536-541.
71. Wang, WC, Wynn, LW, Rogers, ZR, Scott, JP, Lane, PA and Ware, RE (2001) A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. J Pediatr, 139, pp. 790-796.
72. Foster, PN and Losowsky, MS (1987) Hyposplenism - a review. J R Coll Physicians Lond, 21, pp. 188-191.
73. McCarthy, CF, Fraser, ID, Evans, KT and Read, AE (1966) Lymphoreticular dysfunction in idiopathic steatorrhoea. Gut, 7, pp. 140-148.
74. Marsh, GW and Stewart, JS (1970) Splenic function in adult coeliac disease. Br J Haematol, 19, pp. 445-457.
75. Corazza, GR, Lazzari, R., Frisoni, M., Collina, A. and Gasbarrini, G. (1982) Splenic function in childhood coeliac disease. Gut, 23, pp. 415-416.
76. Foster, PN and Losowsky, MS (1987) Hyposplenism - a review. J R Coll Physicians Lond, 21, pp. 188-191.
77. Fish, JC, Beathard, G., Sarles, HE, Remmers Jr, AR and Ritzmann, SE (1970) Circulating lymphocyte depletion: Effect on lymphoid tissue. Surgery, 67, pp. 658-666.
78. Palmer, KR, Barber, DC, Sherriff, SB and Holdsworth, CD (1983) Reticuloendothelial function in coeliac disease and ulcerative colitis. Gut, 24, pp. 384-388.
79. Wardrop, CA, Dagg, JH, Lee, FD, Singh, H., Dyet, JF and Moffat, A. (1975) Immunological abnormalities in splenic atrophy. Lancet, 2, pp. 4-7.
80. Corazza, GR, Frisoni, M., Vaira, D. and Gasbarrini, G. (1983) Effect of gluten-free diet on splenic hypofunction of adult coeliac disease. Gut, 24, pp. 228-230.
81. Trewby, PN, Chipping, PM, Palmer, SJ, Roberts, PD, Lewis, SM and Stewart, JS (1981) Splenic atrophy in adult coeliac disease: Is it reversible?. Gut, 22, pp. 628-632.
82. Corazza, GR, Frisoni, M., Vaira, D. and Gasbarrini, G. (1983) Effect of gluten-free diet on splenic hypofunction of adult coeliac disease. Gut, 24, pp. 228-230.
83. O'Grady, JG, Stevens, FM, Harding, B., O'Gorman, TA, McNicholl, B. and McCarthy, CF (1984) Hyposplenism and gluten-sensitive enteropathy. Natural history, incidence, and relationship to diet and small bowel morphology. Gastroenterology, 87, pp. 1326-1331.
84. Corazza, GR, Zoli, G., Sabatino, A Di, Ciccocioppo, R. and Gasbarrini, G. (1999) A reassessment of splenic hypofunction in celiac disease. Am J Gastroenterol, 94, pp. 391-397.
85. Corazza, GR, Bullen, AW, Hall, R., Robinson, PJ and Losowsky, MS (1981) Simple method of assessing splenic function in coeliac disease. Clin Sci (Lond), 60, pp. 109-113.
86. Trewby, PN, Chipping, PM, Palmer, SJ, Roberts, PD, Lewis, SM and Stewart, JS (1981) Splenic atrophy in adult coeliac disease: Is it reversible?. Gut, 22, pp. 628-632.
87. O'Grady, JG, Stevens, FM, Harding, B., O'Gorman, TA, McNicholl, B. and McCarthy, CF (1984) Hyposplenism and gluten-sensitive enteropathy. Natural history, incidence, and relationship to diet and small bowel morphology. Gastroenterology, 87, pp. 1326-1331.
88. Carroccio, A., Giannitrapani, L., Prima, L Di, Iannitto, E., Montalto, G. and Notarbartolo, A. (2002) Extreme thrombocytosis as a sign of coeliac disease in the elderly: Case report. Eur J Gastroenterol Hepatol, 14, pp. 897-900.
89. Pettit, JE, Hoffbrand, AV, Seah, PP and Fry, L. (1972) Splenic atrophy in dermatitis herpetiformis. Br Med J, 2, pp. 438-440.
90. Schmitz, F., Herzig, KH, Stuber, E., Tiemann, M., Reinecke-Luthge, A. and Nitsche, R. (2002) On the pathogenesis and clinical course of mesenteric lymph node cavitation and hyposplenism in coeliac disease. Int J Colorectal Dis, 17, pp. 192-198.
91. Quellec, A Le, Ciurana, AJ, Greth, I., Eliaou, JF and Pages, A. (1990) Hemorrhagic necrosis of the mesenteric lymph nodes in adult celiac disease. Physiopathologic interpretation of 1 case. Ann Pathol, 10, pp. 194-197.
92. Arotcarena, R., Hammel, P., Terris, B., Guth, A., Bernades, P. and Ruszniewski, P. (2000) Regression of mesenteric lymph node cavitation syndrome complicating celiac disease after a gluten free diet. Gastroenterol Clin Biol, 24, pp. 579-581.
93. Arotcarena, R., Hammel, P., Terris, B., Guth, A., Bernades, P. and Ruszniewski, P. (2000) Regression of mesenteric lymph node cavitation syndrome complicating celiac disease after a gluten free diet. Gastroenterol Clin Biol, 24, pp. 579-581.
94. Robertson, DA, Swinson, CM, Hall, R. and Losowsky, MS (1982) Coeliac disease, splenic function, and malignancy. Gut, 23, pp. 666-669.
95. Stevens, FM, Connolly, CE, Murray, JP and McCarthy, CF (1990) Lung cavities in patients with coeliac disease. Digestion, 46, pp. 72-80.
96. Ryan, FP, Smart, RC, Holdsworth, CD and Preston, FE (1978) Hyposplenism in inflammatory bowel disease. Gut, 19, pp. 50-55.
97. Ryan, FP, Smart, R., Preston, FE and Holdsworth, CD (1974) Hyposplenism in ulcerative colitis. Lancet, 2, pp. 318-320.
98. Palmer, KR, Sherriff, SB, Holdsworth, CD and Ryan, FP (1981) Further experience of hyposplenism in inflammatory bowel disease. Q J Med, 50, pp. 463-471.
99. Ryan, FP, Smart, RC, Holdsworth, CD and Preston, FE (1978) Hyposplenism in inflammatory bowel disease. Gut, 19, pp. 50-55.
100. Muller, AF, Cornford, E. and Toghill, PJ (1993) Splenic function in inflammatory bowel disease: Assessment by differential interference microscopy and splenic ultrasound. Q J Med, 86, pp. 333-340.
101. Pereira, JL, Hughes, LE and Young, HL (1987) Spleen size in patients with inflammatory bowel disease. Does it have any clinical significance?. Dis Colon Rectum, 30, pp. 403-409.
102. Muller, AF, Cornford, E. and Toghill, PJ (1993) Splenic function in inflammatory bowel disease: Assessment by differential interference microscopy and splenic ultrasound. Q J Med, 86, pp. 333-340.
103. Palmer, KR, Sherriff, SB, Holdsworth, CD and Ryan, FP (1981) Further experience of hyposplenism in inflammatory bowel disease. Q J Med, 50, pp. 463-471.
104. Jewell, DP, Berney, JJ and Pettit, JE (1981) Splenic phagocytic function in patients with inflammatory bowel disease. Pathology, 13, pp. 717-723.
105. Douglas, AP, Weetman, AP and Haggith, JW (1976) The distribution and enteric loss of 51Cr-labelled lymphocytes in normal subjects and in patients with coeliac disease and other disorders of the small intestine. Digestion, 14, pp. 29-43.
106. Doe, WF, Booth, CC and Brown, DL (1973) Evidence for complement-binding immune complexes in adult coeliac disease, Crohn's disease, and ulcerative colitis. Lancet, 1, pp. 402-403.
107. Palmer, KR, Barber, DC, Sherriff, SB and Holdsworth, CD (1983) Reticuloendothelial function in coeliac disease and ulcerative colitis. Gut, 24, pp. 384-388.
108. Palmer, KR, Barber, DC, Sherriff, SB and Holdsworth, CD (1983) Reticuloendothelial function in coeliac disease and ulcerative colitis. Gut, 24, pp. 384-388.
109. Sabatino, A Di, Rosado, MM, Ciccocioppo, R., Cazzola, P., Morera, R. and Corazza, GR (2005) Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease. Am J Gastroenterol, 100, pp. 1788-1795.
110. Freeman, HJ (1996) Functional asplenia and microscopic (collagenous) colitis. Can J Gastroenterol, 10, pp. 443-446.
111. Muller, AF and Toghill, PJ (1995) Hyposplenism in gastrointestinal disease. Gut, 36, pp. 165-167.
112. Suarez, RM, Spies, TD and Suarez, RMJ (1947) The use of folic acid in sprue. Ann Intern Med, 26, pp. 643-647.
113. Haeney, MR and Ross, IN (1978) Whipple's disease in a female with impaired cell-mediated immunity unresponsive to co-trimoxazole and levamisole therapy. Postgrad Med J, 54, pp. 45-50.
114. Foster, PN, Bullen, AW, Robertson, DA, Chalmers, DM and Losowsky, MS (1985) Development of impaired splenic function in intestinal lymphangiectasia. Gut, 26, pp. 861-864.
115. Mills, PR, Brown, IL and Watkinson, G. (1980) Idiopathic chronic ulcerative enteritis. Report of five cases and review of the literature. Q J Med, 49, pp. 133-149.
116. Zoli, G., Corazza, GR, Wood, S., Bartoli, R., Gasbarrini, G. and Farthing, MJ (1998) Impaired splenic function and tuftsin deficiency in patients with intestinal failure on long term intravenous nutrition. Gut, 43, pp. 759-762.
117. Seidner, DL, Mascioli, EA, Istfan, NW, Porter, KA, Selleck, K. and Blackburn, GL (1989) Effects of long-chain triglyceride emulsions on reticuloendothelial system function in humans. JPEN J Parenter Enteral Nutr, 13, pp. 614-619.
118. Jensen, GL, Mascioli, EA, Seidner, DL, Istfan, NW, Domnitch, AM and Selleck, K. (1990) Parenteral infusion of long- and medium-chain triglycerides and reticuloendothelial system function in man. JPEN J Parenter Enteral Nutr, 14, pp. 467-471.
119. Zoli, G., Corazza, GR, Wood, S., Bartoli, R., Gasbarrini, G. and Farthing, MJ (1998) Impaired splenic function and tuftsin deficiency in patients with intestinal failure on long term intravenous nutrition. Gut, 43, pp. 759-762.
120. Muller, AF and Toghill, PJ (1992) Splenic function in alcoholic liver disease. Gut, 33, pp. 1386-1389.
121. Muller, AF and Toghill, PJ (1994) Functional hyposplenism in alcoholic liver disease: A toxic effect of alcohol?. Gut, 35, pp. 679-682.
122. Niemela, O., Klajner, F., Orrego, H., Vidins, E., Blendis, L. and Israel, Y. (1987) Antibodies against acetaldehyde-modified protein epitopes in human alcoholics. Hepatology, 7, pp. 1210-1214.
123. Lieber, CS (1991) Perspectives: Do alcohol calories count?. Am J Clin Nutr, 54, pp. 976-982.
124. Satapathy, SK, Narayan, S., Varma, N., Dhiman, RK, Varma, S. and Chawla, Y. (2001) Hyposplenism in alcoholic cirrhosis, facts or artifacts? A comparative analysis with non-alcoholic cirrhosis and extrahepatic portal venous obstruction. J Gastroenterol Hepatol, 16, pp. 1038-1043.
125. Corazza, GR, Addolorato, G., Biagi, F., Caputo, F., Castelli, E. and Stefanini, GF (1997) Splenic function and alcohol addiction. Alcohol Clin Exp Res, 21, pp. 197-200.
126. Pirovino, M., Lydick, E., Grob, PJ, Arrenbrecht, S., Altorfer, J. and Schmid, M. (1984) Pneumococcal vaccination: The response of patients with alcoholic liver cirrhosis. Hepatology, 4, pp. 946-949.
127. Trevisani, F., Castelli, E., Foschi, FG, Parazza, M., Loggi, E. and Bertelli, M. (2002) Impaired tuftsin activity in cirrhosis: Relationship with splenic function and clinical outcome. Gut, 50, pp. 707-712.
128. Dhawan, VM, Spencer, RP and Sziklas, JJ (1979) Reversible functional asplenia in chronic aggressive hepatitis. J Nucl Med, 20, pp. 34-36.
129. Jaffe, CJ, Vierling, JM, Jones, EA, Lawley, TJ and Frank, MM (1978) Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis. J Clin Invest, 62, pp. 1069-1077.
130. Markus, HS, Muller, AF and Toghill, PJ (1993) Splenic function, assessed by quantification of erythrocyte membrane pits, is normal in chronic active hepatitis and primary biliary cirrhosis. J Hepatol, 18, pp. 106-111.
131. Dillon, AM, Stein, HB and English, RA (1982) Splenic atrophy in systemic lupus erythematosus. Ann Intern Med, 96, pp. 40-43.
132. Neilan, BA and Berney, SN (1983) Hyposplenism in systemic lupus erythematosus. J Rheumatol, 10, pp. 332-334.
133. Frank, MM, Hamburger, MI, Lawley, TJ, Kimberly, RP and Plotz, PH (1979) Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med, 300, pp. 518-523.
134. Lockwood, CM, Worlledge, S., Nicholas, A., Cotton, C. and Peters, DK (1979) Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med, 300, pp. 524-530.
135. Elkon, KB, Sewell, JR, Ryan, PF and Hughes, GR (1980) Splenic function in non-renal systemic lupus erythematosus. Am J Med, 69, pp. 80-82.
136. Lockwood, CM, Worlledge, S., Nicholas, A., Cotton, C. and Peters, DK (1979) Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med, 300, pp. 524-530.
137. Santilli, D., Govoni, M., Prandini, N., Rizzo, N. and Trotta, F. (2003) Autosplenectomy and antiphospholipid antibodies in systemic lupus erythematosus: A pathogenetic relationship?. Semin Arthritis Rheum, 33, pp. 125-133.
138. Pettersson, T. and Julkunen, H. (1992) Asplenia in a patient with systemic lupus erythematosus and antiphospholipid antibodies. J Rheumatol, 19, p. 1159.
139. Fields, TR, Zarrabi, MH, Gerardi, EN, Bennett, RS, Zucker, S. and Hamburger, MI (1986) Reticuloendothelial system Fc receptor function in the drug induced lupus erythematosus syndrome. J Rheumatol, 13, pp. 726-731.
140. Williams, BD, Pussell, BA, Lockwood, CM and Cotton, C. (1979) Defective reticuloendothelial system function in rheumatoid arthritis. Lancet, 1, pp. 1311-1314.
141. Gordon, PA, Davis, P., Russell, AS, Coates, JE, Rothwell, RS and LeClercq, SM (1981) Splenic reticuloendothelial function in patients with active rheumatoid arthritis. J Rheumatol, 8, pp. 490-493.
142. Henderson, JM, Bell, DA, Harth, M. and Chamberlain, MJ (1981) Reticuloendothelial function in rheumatoid arthritis: Correlation with disease activity and circulating immune complexes. J Rheumatol, 8, pp. 486-489.
143. Gordon, PA, Davis, P., Russell, AS, Coates, JE, Rothwell, RS and LeClercq, SM (1981) Splenic reticuloendothelial function in patients with active rheumatoid arthritis. J Rheumatol, 8, pp. 490-493.
144. Henderson, JM, Bell, DA, Harth, M. and Chamberlain, MJ (1981) Reticuloendothelial function in rheumatoid arthritis: Correlation with disease activity and circulating immune complexes. J Rheumatol, 8, pp. 486-489.
145. Brownlie, BE, Hamer, JW, Cook, HB and Hamwood, SM (1975) Letter: Thyrotoxicosis associated with splenic atrophy. Lancet, 2, pp. 1046-1047.
146. Jellinek, EH and Ball, K. (1976) Letter: Hashimoto's disease, encephalopathy, and splenic atrophy. Lancet, 1, p. 1248.
147. Wardrop, CA, Dagg, JH, Lee, FD, Singh, H., Dyet, JF and Moffat, A. (1975) Immunological abnormalities in splenic atrophy. Lancet, 2, pp. 4-7.
148. Lockwood, CM, Worlledge, S., Nicholas, A., Cotton, C. and Peters, DK (1979) Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med, 300, pp. 524-530.
149. McGinley, E., Martin, W., Henderson, N. and Boulton-Jones, JM (1984) Defective splenic reticuloendothelial function in idiopathic membranous nephropathy. Clin Exp Immunol, 56, pp. 295-301.
150. Frank, MM, Lawley, TJ, Hamburger, MI and Brown, EJ (1983) NIH Conference: Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseases. Ann Intern Med, 98, pp. 206-218.
151. Winston, DJ, Schiffman, G., Wang, DC, Feig, SA, Lin, CH and Marso, EL (1979) Pneumococcal infections after human bone-marrow transplantation. Ann Intern Med, 91, pp. 835-841.
152. Atkinson, K., Storb, R., Prentice, RL, Weiden, PL, Witherspoon, RP and Sullivan, K. (1979) Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood, 53, pp. 720-731.
153. Demetrakopoulos, GE, Tsokos, GC and Levine, AS (1982) Recovery of splenic function after GVHD-associated functional asplenia. Am J Hematol, 12, pp. 77-80.
154. Eid, MA Al, Tutschka, PJ, Wagner Jr, HN, Santos, GW and Tsan, MF (1983) Functional asplenia in patients with chronic graft-versus-host disease: Concise communication. J Nucl Med, 24, pp. 1123-1126.
155. Kalhs, P., Panzer, S., Kletter, K., Minar, E., Stain-Kos, M. and Walter, R. (1988) Functional asplenia after bone marrow transplantation. A late complication related to extensive chronic graft-versus-host disease. Ann Intern Med, 109, pp. 461-464.
156. Cuthbert, RJ, Iqbal, A., Gates, A., Toghill, PJ and Russell, NH (1995) Functional hyposplenism following allogeneic bone marrow transplantation. J Clin Pathol, 48, pp. 257-259.
157. Picardi, M., Selleri, C. and Rotoli, B. (1999) Spleen sizing by ultrasound scan and risk of pneumococcal infection in patients with chronic GVHD: Preliminary observations. Bone Marrow Transplant, 24, pp. 173-177.
158. Buchanan, GR and Holtkamp, CA (1985) Splenic reticuloendothelial function in children with cancer. J Pediatr, 106, pp. 239-242.
159. Simoes, BP, Tone, LG, Zago, MA and Figueiredo, MS (1995) Splenic function in acute leukemia. Acta Haematol, 94, pp. 123-127.
160. Gross, DJ, Braverman, AJ, Koren, G., Rabinowitz, YS, Gordon, R. and Okon, E. (1982) Functional asplenia in immunoblastic lymphoma. Arch Intern Med, 142, pp. 2213-2215.
161. Pettit, JE, Williams, ED, Glass, HI, Lewis, SM, Szur, L. and Wicks, CJ (1971) Studies of splenic function in the myeloproliferative disorders and generalized malignant lymphomas. Br J Haematol, 20, pp. 575-586.
162. Pavlotsky, F., Mekhmandarov, S. and Mozes, B. (1989) Functional hyposplenism in a patient with advanced breast cancer. Isr J Med Sci, 25, pp. 589-591.
163. Costello, P., Gramm, HF and Steinberg, D. (1977) Simultaneous occurrence of functional asplenia and splenic accumulation of diphosphonate in metastatic breast carcinoma. J Nucl Med, 18, pp. 1237-1238.
164. Pettit, JE (1977) Spleen function. Clin Haematol, 6, pp. 639-656.
165. Steinberg, MH, Gatling, RR and Tavassoli, M. (1983) Evidence of hyposplenism in the presence of splenomegaly. Scand J Haematol, 31, pp. 437-439.
166. Yucel, AE, Durak, H., Bernay, I., Bayraktar, Y., Bekdik, C. and Telatar, H. (1990) Functional asplenia and portal hypertension in a patient with primary splenic hemangiosarcoma. Clin Nucl Med, 15, pp. 324-326.
167. Budke, HL, Breitfeld, PP and Neiman, RS (1995) Functional hyposplenism due to a primary epithelioid hemangioendothelioma of the spleen. Arch Pathol Lab Med, 119, pp. 755-757.
168. Pichler, WJ, Peter, HH, Anagnou, J., Kaup, FJ and Drommer, W. (1984) Sezary syndrome with hyposplenism. Blut, 49, pp. 75-82.
169. Marsh, GW, Lewis, SM and Szur, L. (1966) The use of 51Cr-labelled heat-damaged red cells to study splenic function. II. Splenic atrophy in thrombocythaemia. Br J Haematol, 12, pp. 167-171.
170. Roth, J., Brudler, O. and Henze, E. (1985) Functional asplenia in malignant mastocytosis. J Nucl Med, 26, pp. 1149-1152.
171. Ozkaynak, MF, Ortega, JA and Miller, J. (1990) Concurrence of transient asplenia and pure red cell aplasia. Eur J Pediatr, 149, pp. 542-544.
172. Garriga, S. and Crosby, WH (1959) The incidence of leukemia in families of patients with hypoplasia of the marrow. Blood, 14, pp. 1008-1014.
173. Spencer, RP, Johnson, PM and Sziklas, JJ (1977) Unusual scan presentation of splenic vasculature occlusion by tumor. Clin Nucl Med, 2, pp. 197-199.
174. Hirano, T., Tomiyoshi, K., Take, H., Watanabe, N., Oriuchi, N. and Inoue, T. (1994) Reversible functional asplenia. Autoimmune hemolytic anemia with thrombocytopenia in chronic lymphocytic leukemia. Clin Nucl Med, 19, pp. 693-695.
175. Dailey, MO, Coleman, CN and Kaplan, HS (1980) Radiation-induced splenic atrophy in patients with Hodgkin's disease and non-Hodgkin's lymphomas. N Engl J Med, 302, pp. 215-217.
176. Coleman, CN, McDougall, IR, Dailey, MO, Ager, P., Bush, S. and Kaplan, HS (1982) Functional hyposplenia after splenic irradiation for Hodgkin's disease. Ann Intern Med, 96, pp. 44-47.
177. Coleman, CN, McDougall, IR, Dailey, MO, Ager, P., Bush, S. and Kaplan, HS (1982) Functional hyposplenia after splenic irradiation for Hodgkin's disease. Ann Intern Med, 96, pp. 44-47.
178. Grotto, HZ and Costa, FF (1991) Hyposplenism in AIDS. AIDS, 5, pp. 1538-1540.
179. Ong, KR, Stavropoulos, C. and Inada, Y. (1990) Babesiosis, asplenia, and AIDS. Lancet, 336, p. 112.
180. Khan, AM, Harrington, RD, Nadel, M. and Greenberg, BR (1998) Hyposplenism from Mycobacterium avium complex infection in a patient with AIDS and immune thrombocytopenia. Acta Haematol, 99, pp. 45-48.
181. Eshel, Y., Sarova-Pinhas, I. Lampl, Y. and Jedwab, M. (1991) Autosplenectomy complicating pneumococcal meningitis in an adult. Arch Intern Med, 151, pp. 998-999.
182. Markus, HS and Toghill, PJ (1991) Impaired splenic function in elderly people. Age Ageing, 20, pp. 287-290.
183. Zago, MA (1989) The evaluation of spleen function in man. Braz J Med Biol Res, 22, pp. 159-169.
184. Ravaglia, G., Forti, P., Biagi, F., Maioli, F., Boschi, F. and Corazza, GR (1998) Splenic function in old age. Gerontology, 44, pp. 91-94.
185. Gertz, MA, Kyle, RA and Greipp, PR (1983) Hyposplenism in primary systemic amyloidosis. Ann Intern Med, 98, pp. 475-477.
186. Guyton, JR and Zumwalt, RE (1975) Letter: Pneumococcemia with sarcoid-infiltrated spleen. Ann Intern Med, 82, pp. 847-848.
187. Dhawan, VM, Spencer, RP and Pearson, HA (1977) Functional asplenia in the absence of circulating Howell-Jolly bodies. Clin Nucl Med, 2, pp. 395-396.
188. Ramsahoye, BH, Evely, R., Mumar-Bashi, W. and Lim, SH (1994) Selective IgA deficiency and hyposplenism. Clin Lab Haematol, 16, pp. 375-377.
189. Foster, PN and Losowsky, MS (1987) Hyposplenism - a review. J R Coll Physicians Lond, 21, pp. 188-191.
190. Fahy, G., Robinson, K., Deb, B. and Graham, I. (1992) Primary pulmonary hypertension and functional hyposplenism. Postgrad Med J, 68, pp. 383-385.
191. Kelton, JG (1985) Impaired reticuloendothelial function in patients treated with methyldopa. N Engl J Med, 313, pp. 596-600.
192. Dekker, PT and Propp, RP (1977) Functional asplenia in idiopathic thrombocytopenic purpura. N Y State J Med, 77, pp. 2282-2285.
193. Johnson, SA, Bateman, CJ, Beard, ME, Whitehouse, JM and Waters, AH (1977) Long-term haematological complications of thorotrast. Q J Med, 46, pp. 259-271.